OsteoarthritisNCT00405379
Trabecular Metal Mesh Tibial Monoblock RSA
A study testing Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty in people with Osteoarthritis, run by Dalhousie University.
Trial summary
Trabecular Metal(TM) is a relatively new technology and its use in knee replacement is quite different from the more conventional total knee replacement (arthroplastie). The aim of incorporating TMM into the material used for the knee replacement (tibial prostheses) is to improve initial fixation of the prosthesis at… Read more about this study
- Who is it for?
- Ages 55 to 80 years
- Conditions the study is for
- Osteoarthritis
- What is being tested?
- Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty
- Type of treatment
- Medical device
- How many people
- 67 participants
- Where
- No sites listed yet
- Study dates
- Jul 2002to Feb 2007
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age between 55 and 80
- Primary osteoarthritis of the knee
- Mono-articular disease (Charnley Modified Type A)
Who cannot join
- Significant co-morbidity affecting ability to ambulate
- Flexion contracture greater than 15°
- Tibial subluxation greater than 10 mm on standing AP radiograph
- Greater than 10° of varus or 15° of valgus
- Extension lag greater than 10°
- Lateral or medial collateral ligament instability (> 10° varus/valgus)
Show all 12Show fewer
- Previous osteotomy about the knee
- Previous arthroplasty of the knee
- Previous patellectomy
- Posterior cruciate ligament deficiency
- Leg length discrepancy greater than 10 mm
- Morbid obesity
About this study
Official title: A Prospective Randomized Controlled Trial Using Roentgen Stereophotogrammetric Analysis of Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty Component "TMM".
Trabecular Metal(TM) is a relatively new technology and its use in knee replacement is quite different from the more conventional total knee replacement (arthroplastie). The aim of incorporating TMM into the material used for the knee replacement (tibial prostheses) is to improve initial fixation of the prosthesis at the time of implantation (surgery) and to improve long term prosthesis survival by encouraging and improving bone ingrowth.
Read the detailed description
Hip and knee replacement arthroplasty are profoundly successful operative interventions, however, some joint replacements do fail and the life expectancy of a hip or knee arthroplasty is finite (Malchau et al. 1993, Knutson et al. 1994, Herberts et al. 1997, Garellick et al. 1998). This fact has largely been responsible for the continued development of new devices and techniques for joint arthroplasty surgery. Unfortunately, the introduction of new technologies and devices is not a benign process, and even subtle changes to existing implants can have a disastrous effect on patient outcome (Sudmann et al. 1983, Herberts P. 1986, Ohlin et al. 1989, Wedderkopp et al. 1997, Howie et al. 1998, Nilsson et al. 1998).
The fact that new technologies and devices can lead to poor results has led some authors to advocate a phased introduction of new technologies (Gross 1988, Gross 1993, Malchau 1999). A key component of the phased introduction approach advocates the use of roentgen stereophotogrammetric analysis (RSA) early in the testing process (Malchau 1999).
RSA is a highly accurate radiographic technique developed in Lund, Sweden and has for some time been the gold standard in Europe for assessing the stability of implants within bone (Selvik 1990, Ryd 1992, Catani et al. 1998, Alfaro-Adrian et al. 1999). It is at least ten times more accurate than conventional radiography (Ryd et al. 1986). RSA involves the insertion of small tantalum markers (0.8mm) into the bone and prosthesis at the time of surgery (Ryd 1986, Ryd et al. 1986, Ryd et al. 1989, Selvik 1990, Ryd 1992). By using a calibrated cage with additional markers and simultaneous bi-planar x-rays, micromotion at the prosthesis-bone interface can be very precisely determined (Selvik et al. 1983). Two types of micromotion can be investigated: migration, i.e. gradual motion over time, and inducible displacement, i.e. instant motion in response to external forces (Ryd et al. 1986). The pattern of micromotion exhibited by various prostheses and fixation techniques within the first post-operative year has been shown to be predictive of the long-term fixation of the component to bone, especially when considering the tibial prosthesis-bone interface (Ryd 1986, Ryd et al. 1986, Ryd 1992, Ryd et al. 1995). The value of this precise radiographic technique is that new technologies and techniques can be introduced in vivo while limiting their exposure to as few patients as possible. RSA is a proven, safe and invaluable method for assessing methods of tibial component fixation as well as different design concepts (Ryd et al. 1987, Nilsson et al. 1991, Ryd et al. 1992, Ryd et al. 1993, Hilding et al. 1995, Onsten et al. 1998, Nilsson et al. 1999).
Until recently, RSA technology has been cumbersome and expensive. However, significant advances have made the system more applicable due to the fact that digitized films are being used, and computer programs have been written and can run on small personal computers that will allow for automatic capture and interpretation of x-ray markers and implants (Vrooman et al. 1998).
Trabecular Metal(TM) is a relatively new technology and its use in tibial knee arthroplasty components represents a significant departure from conventional total knee arthroplasties. TM has a high co-efficient of friction and high affinity for bone ingrowth (Bobyn et al. 1999a, Bobyn et al. 1999b, Hacking et al. 2000), subsequently, the aims of incorporating TMM into tibial prostheses is to improve initial fixation of the tibial prosthesis at the time of implantation and to improve long term prosthesis survival by facilitating bone ingrowth. Such advantages remain, however, theoretical, and have yet to be demonstrated in vivo for total knee arthroplasty. With conventional study techniques, a definitive answer to the effect of the prosthetic design on fixation of the tibial component would require a large number of patients and approximately 10 years of follow-up (Ryd 1992, Ryd et al. 1995). RSA provides a means of accurately assessing the tibial component fixation, both immediate and long term, on a relatively small number of patients within two years of the onset of the study. It is critical at this stage to determine the long-term effect of this design concept on component fixation so that any deleterious effects can be addressed and any advantageous effects can be disseminated to the orthopaedic community.
- Conditions
- Osteoarthritis
- Being tested
- Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty
- Keywords
- arthroplasty, RSA, Osteoarthritis, trabecular metal mesh
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Trabecular Metal Mesh Tibial Monoblock Knee ArthroplastyDevice
new porous metal tibial component with potential to result in improved bone in-growth and implant integration with proximal tibia
What is being measured
The primary outcome is the main question the study is designed to answer.
micromotion of tibial component
Measured: 2 years postoperative
Secondary outcomes (1)
subjective outcomes measured with health outcome questionnaires sf36, WOMAC
Measured: 2 years postoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Nov 2006 (estimated)
- Study startJul 2002
- Primary completionAug 2006
- Study completionFeb 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 67 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dalhousie University
- Sponsor type
- University, hospital or other
- Collaborators
- Stryker Trauma and Extremities
- Investigators
- Michael J Dunbar, MD FRCSC PhD, Principal investigator, Dalhousie University & Capital Districk Health Authority
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00405379
- Sponsor's protocol ID
- DAL06-02
- Other IDs
- CDHA-RS/2002-096
- Status last verified
- Apr 2008
- First submitted
- 28 Nov 2006
- Last updated
- 10 Apr 2008
- Results posted
- No
- Data monitoring committee
- No
Publications
Astephen Wilson JL, Wilson DA, Dunbar MJ, Deluzio KJ. Preoperative gait patterns and BMI are associated with tibial component migration. Acta Orthop. 2010 Aug;81(4):478-86. doi: 10.3109/17453674.2010.501741.
PubMed 20809746
Study at a glance
From the registry record, last updated by the sponsor on 10 Apr 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Randomized Controlled Trial Using Roentgen Stereophotogrammetric Analysis of Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty Component "TMM".
- ClinicalTrials.gov ID
- NCT00405379
- Acronym / sponsor ID
- DAL06-02
- Conditions
- Osteoarthritis
- Keywords
- arthroplasty, RSA, Osteoarthritis, trabecular metal mesh
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 67 participants (actual)
- Lead sponsor
- Dalhousie UniversityUniversity, hospital or other
- Collaborators
- Stryker Trauma and Extremities
- Study start
- Jul 2002
- Primary completion
- Aug 2006 (actual)
- Study completion
- Feb 2007 (actual)
- First posted
- 30 Nov 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Trabecular Metal(TM) is a relatively new technology and its use in knee replacement is quite different from the more conventional total knee replacement (arthroplastie). The aim of incorporating TMM into the material used for the knee replacement (tibial prostheses) is to improve initial fixation of the prosthesis at the time of implantation (surgery) and to improve long term prosthesis survival by encouraging and improving bone ingrowth.
Detailed description
Hip and knee replacement arthroplasty are profoundly successful operative interventions, however, some joint replacements do fail and the life expectancy of a hip or knee arthroplasty is finite (Malchau et al. 1993, Knutson et al. 1994, Herberts et al. 1997, Garellick et al. 1998). This fact has largely been responsible for the continued development of new devices and techniques for joint arthroplasty surgery. Unfortunately, the introduction of new technologies and devices is not a benign process, and even subtle changes to existing implants can have a disastrous effect on patient outcome (Sudmann et al. 1983, Herberts P. 1986, Ohlin et al. 1989, Wedderkopp et al. 1997, Howie et al. 1998, Nilsson et al. 1998).
The fact that new technologies and devices can lead to poor results has led some authors to advocate a phased introduction of new technologies (Gross 1988, Gross 1993, Malchau 1999). A key component of the phased introduction approach advocates the use of roentgen stereophotogrammetric analysis (RSA) early in the testing process (Malchau 1999).
RSA is a highly accurate radiographic technique developed in Lund, Sweden and has for some time been the gold standard in Europe for assessing the stability of implants within bone (Selvik 1990, Ryd 1992, Catani et al. 1998, Alfaro-Adrian et al. 1999). It is at least ten times more accurate than conventional radiography (Ryd et al. 1986). RSA involves the insertion of small tantalum markers (0.8mm) into the bone and prosthesis at the time of surgery (Ryd 1986, Ryd et al. 1986, Ryd et al. 1989, Selvik 1990, Ryd 1992). By using a calibrated cage with additional markers and simultaneous bi-planar x-rays, micromotion at the prosthesis-bone interface can be very precisely determined (Selvik et al. 1983). Two types of micromotion can be investigated: migration, i.e. gradual motion over time, and inducible displacement, i.e. instant motion in response to external forces (Ryd et al. 1986). The pattern of micromotion exhibited by various prostheses and fixation techniques within the first post-operative year has been shown to be predictive of the long-term fixation of the component to bone, especially when considering the tibial prosthesis-bone interface (Ryd 1986, Ryd et al. 1986, Ryd 1992, Ryd et al. 1995). The value of this precise radiographic technique is that new technologies and techniques can be introduced in vivo while limiting their exposure to as few patients as possible. RSA is a proven, safe and invaluable method for assessing methods of tibial component fixation as well as different design concepts (Ryd et al. 1987, Nilsson et al. 1991, Ryd et al. 1992, Ryd et al. 1993, Hilding et al. 1995, Onsten et al. 1998, Nilsson et al. 1999).
Until recently, RSA technology has been cumbersome and expensive. However, significant advances have made the system more applicable due to the fact that digitized films are being used, and computer programs have been written and can run on small personal computers that will allow for automatic capture and interpretation of x-ray markers and implants (Vrooman et al. 1998).
Trabecular Metal(TM) is a relatively new technology and its use in tibial knee arthroplasty components represents a significant departure from conventional total knee arthroplasties. TM has a high co-efficient of friction and high affinity for bone ingrowth (Bobyn et al. 1999a, Bobyn et al. 1999b, Hacking et al. 2000), subsequently, the aims of incorporating TMM into tibial prostheses is to improve initial fixation of the tibial prosthesis at the time of implantation and to improve long term prosthesis survival by facilitating bone ingrowth. Such advantages remain, however, theoretical, and have yet to be demonstrated in vivo for total knee arthroplasty. With conventional study techniques, a definitive answer to the effect of the prosthetic design on fixation of the tibial component would require a large number of patients and approximately 10 years of follow-up (Ryd 1992, Ryd et al. 1995). RSA provides a means of accurately assessing the tibial component fixation, both immediate and long term, on a relatively small number of patients within two years of the onset of the study. It is critical at this stage to determine the long-term effect of this design concept on component fixation so that any deleterious effects can be addressed and any advantageous effects can be disseminated to the orthopaedic community.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
Who may qualify
- Ages
- 55 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age between 55 and 80
- Primary osteoarthritis of the knee
- Mono-articular disease (Charnley Modified Type A)
Key exclusion criteria (12 listed)
- Significant co-morbidity affecting ability to ambulate
- Flexion contracture greater than 15°
- Tibial subluxation greater than 10 mm on standing AP radiograph
- Greater than 10° of varus or 15° of valgus
- Extension lag greater than 10°
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Trabecular Metal Mesh Tibial Monoblock Knee Arthroplastynew porous metal tibial component with potential to result in improved bone in-growth and implant integration with proximal tibia | Device | – |
Primary outcome
micromotion of tibial component
Time frame: 2 years postoperative
1 secondary outcome
subjective outcomes measured with health outcome questionnaires sf36, WOMAC
Time frame: 2 years postoperative
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Apr 2008.
- Derived from this study: PubMed 20809746Astephen Wilson JL, Wilson DA, Dunbar MJ, Deluzio KJ. Preoperative gait patterns and BMI are associated with tibial component migration. Acta Orthop. 2010 Aug;81(4):478-86. doi: 10.3109/17453674.2010.501741.
Related trials for Osteoarthritis
RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Osteoarthritis, Knee, Chronic Pain
Not yet recruiting
EFFECT OF ADDING BLOOD FLOW RESTRICTION TRAINING TO CLOSED CHAIN EXERCISE IN KNEE OSTEOARTHRITIS
Knee Osteoarthritis
Recruiting
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Osteoarthritis, Traumatic Arthritis
Not yet recruiting
Platelet-Rich Plasma, Hyaluronic Acid, or Their Combination for Knee Osteoarthritis in Athletes
Knee Osteoarthritis
Recruiting
Study NRPT Feasibility in Knee Osteoarthritis
Knee Osteoarthristis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michael J Dunbar, MD FRCSC PhD principal investigator
Dalhousie University & Capital Districk Health Authority
Questions about this trial
What is this clinical trial studying?
A study testing Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty in people with Osteoarthritis, run by Dalhousie University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Apr 2008. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
micromotion of tibial component (time frame: 2 years postoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00405379, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2008.